Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician
The incidence of cutaneous malignant melanoma is rising globally and is projected to continue to rise. Advances in immunotherapy over the last decade have demonstrated that manipulation of the immune cell compartment of tumours is a valuable weapon in the arsenal against cancer; however, limitations...
Guardado en:
Autores principales: | Rebecca Adams, Bernhard Moser, Sophia N. Karagiannis, Katie E. Lacy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb8c784ab84545ffbb1f0652f52eebaa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives
por: Sacha Nahon-Estève, et al.
Publicado: (2021) -
Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Huihua Zeng, et al.
Publicado: (2021) -
EVALUATION AND CLINICAL SIGNIFICANCE OF CHEMOKINES AND THEIR SPECIFIC RECEPTORS IN PATIENTS WITH BRONCHIAL ASTHMA
por: A. A. Bibkova, et al.
Publicado: (2014) -
Real-world treatment practice in patients with advanced melanoma
por: Bożena Cybulska-Stopa, et al.
Publicado: (2020) -
CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets
por: Liu F, et al.
Publicado: (2021)